- myLubrizol
-
-
Search Health
Posted by LLS Health Technical Team | 11/10/2021
OEMs and startups alike increasingly see the advantages of working with an integrated medical device development provider that can support projects from concept to commercialization.
Posted by LLS Health Technical Team | 10/26/2021
The need to consistently place the patient at the center of development and manufacturing decisions has been key in the pharma industry. Lubrizol Life Science Health explores the meaning of patient centricity and key considerations that pharmaceutical companies should bear in mind to ensure successful development of a truly patient-centric drug product.
Posted by LLS Health Technical Team | 10/25/2021
The EU Medical Device Regulation 2017/745 (MDR) that went into effect May 26, 2021, presents a number of challenges for medical device manufacturers, especially makers of implantable and invasive devices.
Posted by LLS Health Technical Team | 10/13/2021
The safety of a medical device is of utmost concern and importance at all times during its development, manufacturing, regulatory submission and use. One critical step in establishing the safety of a device is to evaluate how the device interacts with the body. Device makers’ materials suppliers may be helpful in conducting the evaluations at both the material and device levels.
Posted by LLS Health Technical Team | 10/07/2021
In this blog, we discuss key initial formulation considerations when designing mucoadhesive dosage forms, such as those involving the drug, inactive ingredients, and intended site of action.
Posted by LLS Health Technical Team | 08/24/2021
Every market has unique demands when it comes to the properties of oral care products. However, no matter the market, the ability to promote longer-lasting properties of oral care products will give a brand greater appeal in an increasingly saturated marketplace.
Posted by LLS Health Technical Team | 08/19/2021
To penetrate the markets, manufacturers must ensure that drug products comply with the local regulations. In an industry where the global regulatory environment is fragmented, developers and manufacturers need to know the standard of their carbomers.
Posted by LLS Health Technical Team | 08/05/2021
As much as 40-70% of new APIs are poorly water soluble, having negative implication for their effectiveness. To address this issue and ensure the successful commercialization of these products, solubility enhancement is essential. In our latest blog, we explore solubility enhancement techniques.
Posted by LLS Health Technical Team | 07/21/2021
A key factor in the success and effectiveness of many drug products is whether or not they are “mucoadhesive”. In this blog, we will explore four key ways mucoadhesion, when optimized, can improve over-the-counter (OTC) or prescription (Rx) drug products.
Posted by LLS Health Technical Team | 01/28/2021
While advancements in drug delivery are continually improving drug efficacy and bioavailability, there are still significant areas of unmet need in the market. This post discusses some key challenges of oral drug formulations and why they are important to address for patient health and differentiation in a crowded market. We uncover strategies for overcoming these challenges, including extended drug release, taste masking, and tablet size reduction.
Posted by LLS Health Technical Team | 12/08/2020
In this post, Lubrizol Life Science Health (LLS Health) discusses the importance and benefits of topical drug delivery, as well as how these sensory properties are influencing topical development and differentiation. LLS Health then reviews the significance of the FDA's Inactive Ingredient Database (IID) and the components needed to create a topical drug with patient-centric attributes.
Posted by LLS Health Technical Team | 11/09/2020
More than 700 products have made the switch from Rx to OTC over the past several decades, but recent years have seen an upswing. In this blog post, LLS Health discusses growth drivers in Rx-to-OTC switches, the benefits of converting a product to OTC, and how patient considerations are shaping product development.
Posted by LLS Health Technical Team | 10/12/2020
Oral health is an integral part of consumers' mounting desire to lead healthier lifestyles, resulting in industry growth. Increased awareness of oral health coupled with an improved understanding of the underlying causes of oral issues also contribute to the surge; rising market penetration and the growing availability of innovative and differentiated products play a role as well.
Posted by LLS Health Technical Team | 09/16/2020
An aging population, rise in digital screen time, and surge in airborne pollution have increased the incidence of eye disease. These factors have positioned the industry for growth. We are witnessing this growth now, with two ocular drug approvals in the first half of 2020 and at least nine others set to achieve major milestones this year - in this post, Lubrizol Life Science Health reviews these milestones and their implications.
Posted by LLS Health Technical Team | 08/20/2020
The appropriate selection of component materials is often very important in the development and sustainability of a medical device. For many devices, that selection often begins with a designer’s consideration of a range of known medical polymers.
Posted by LLS Health Technical Team | 08/13/2020
OTC medicines treat and alleviate the symptoms of many common ailments, such as pain, cold and flu, heartburn, and acne. Product examples include cough suppressants, analgesics (pain relievers), and antihistamines. In this post, Lubrizol Life Science Health (LLS Health) dives further into OTC classification, trends in the space, and the market outlook.
Posted by LLS Health Technical Team | 06/16/2020
Oral drug administration is critical for the delivery of drugs in various therapeutic areas, such as cardiovascular and pain management. It is considered the preferred route of administration due to its significant advantages, including being both painless and convenient.
Posted by LLS Health Technical Team | 05/27/2020
The inherent structure and physiology of the eye make it difficult for drugs to reach the site of action and persist over time. Despite these constraints, ocular therapies continue to garner significant interest due to growing patient need. Drug product developers are actively seeking options for overcoming these barriers and effectively delivering ophthalmic drugs.
Welcome to the Blog. Our mission is to accelerate your success through partnership and proactive innovation. This blog will provide unique perspectives from the best in the business. We are dedicated to sharing our extensive market knowledge and formulation expertise to help our partners improve patient outcomes.
